Ranmali Ranasinghe
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
-
- Antioxidant Activity and Oxidative Stress
Papers in
- Oncology 5
- Chemokine receptors and signaling 3
- Colorectal Cancer Treatments and Studies 1
-
- IL-33, ST2, and ILC Pathways 2
- T-cell and B-cell Immunology 2
- Co-authors
- Michael L. Mathai (5 shared papers)Anthony Zulli (5 shared papers)Rajaraman Eri (5 shared papers)Mohammed Abdullah Alshawsh (1 shared paper)Madhur D. Shastri (1 shared paper)Dharshana Kasthurirathna (1 shared paper)Agampodi Promoda Perera (1 shared paper)Ruchira Fernando (1 shared paper)
In The Last Decade
Ranmali Ranasinghe
10 papers receiving 294 citations
Peers
Comparison fields: 5 of 89
- Immunology 73
- Biochemistry 20
- Oncology 85
- Pathology and Forensic Medicine 39
- Cancer Research 28
Countries citing papers authored by Ranmali Ranasinghe
This map shows the geographic impact of Ranmali Ranasinghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranmali Ranasinghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranmali Ranasinghe more than expected).
Fields of papers citing papers by Ranmali Ranasinghe
This network shows the impact of papers produced by Ranmali Ranasinghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranmali Ranasinghe. The network helps show where Ranmali Ranasinghe may publish in the future.
Co-authors
The 8 scholars most cited alongside Ranmali Ranasinghe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 95 | |
| 2 | 2018 | 54 | |
| 3 | 2022 | 38 | |
| 4 | 2018 | 36 | |
| 5 | 2023 | 31 | |
| 6 | 2022 | 27 | |
| 7 | 2018 | 9 | |
| 8 | 2018 | 7 | |
| 9 | 2024 | 2 | |
| 10 | 2020 | 2 | |
| 11 | 2021 | 0 |
About Ranmali Ranasinghe
Ranmali Ranasinghe is a scholar working on Oncology, Immunology, Pathology and Forensic Medicine, Molecular Biology and Genetics, having authored 11 papers that have together received 301 indexed citations. Recurring topics across this work include Chemokine receptors and signaling (3 papers), IL-33, ST2, and ILC Pathways (2 papers), Inflammatory Bowel Disease (2 papers), Chemotherapy-induced organ toxicity mitigation (2 papers), T-cell and B-cell Immunology (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Colorectal Cancer Treatments and Studies (1 paper) and Coenzyme Q10 studies and effects (1 paper). The work is most often cited by research in Immunology (73 citations), Biochemistry (20 citations), Oncology (85 citations), Pathology and Forensic Medicine (39 citations) and Cancer Research (28 citations). Ranmali Ranasinghe has collaborated with scholars based in Australia, Sri Lanka and Malaysia. Frequent co-authors include Michael L. Mathai, Anthony Zulli, Rajaraman Eri, Mohammed Abdullah Alshawsh, Madhur D. Shastri, Dharshana Kasthurirathna, Agampodi Promoda Perera and Ruchira Fernando. Their work appears in journals such as Heliyon, Life Sciences, BioFactors, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer and Medicina.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.